I noticed the contradictions in these two statements - the tender offer to purchase all outstanding shares vs. ambs licensing their products.
It does seem like both things can't be true. We just don't have enough info yet, and as usual will be in the dark... until we aren't.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links